Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole with or without Gefitinib in Advanced Breast Cancer
NCT00066378Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2003
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started May 2003; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00066378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066378.